KCNJ15 Gene: Potential Drug Target for Neurological Disorders

Target Name: KCNJ15

NCBI ID: G3772

KCNJ15

KCNJ15 Gene: Potential Drug Target for Neurological Disorders

KCNJ15 (KCNJ15 gene, also known as OTTHUMP00000115740), is a gene that encodes for a protein known as the neurotrophic factor, NGF (Neuron Growth Factor), which is a key regulator of neural growth and development. The NGF protein plays a crucial role in the development and maintenance of neural stem cells, which are the foundation of the nervous system. NGF has also been shown to play a key role in the regulation of pain, and is therefore a potential drug target for the treatment of various neurological disorders.

KCNJ15 gene

The KCNJ15 gene is located on chromosome 18q21 and has been identified as a key regulator of neural stem cell proliferation and differentiation. The gene encodes for a protein that consists of 214 amino acids. The protein has a molecular weight of 21.9 kDa and a pre-membrane N-terminal region of 12 amino acids, as well as a cytoplasmic tail of 10 amino acids.

KCNJ15 gene function

The KCNJ15 gene is responsible for the production of a protein that is involved in the regulation of neural stem cell proliferation and differentiation. This protein is known as the neurotrophic factor, NGF. NGF is a key regulator of neural stem cell proliferation and has been shown to play a crucial role in the development and maintenance of neural stem cells.

In addition to its role in neural stem cell biology, NGF has also been shown to play a key role in the regulation of pain. NGF has been shown to play a critical role in the development of pain fibers, which are the final step in the pain signaling pathway. By regulating the formation of pain fibers, NGF has been shown to play a key role in the regulation of pain.

KCNJ15 gene targeting

The KCNJ15 gene is a potential drug target for the treatment of various neurological disorders. The neurotrophic factor, NGF, has been shown to play a crucial role in the development and maintenance of neural stem cells, which are the foundation of the nervous system. NGF has also been shown to play a key role in the regulation of pain, making it an attractive target for the treatment of pain disorders.

In addition to its potential as a drug target, the KCNJ15 gene is also a potential biomarker for the diagnosis and monitoring of various neurological disorders. For example, altered levels of NGF have been observed in the brains of individuals with certain neurological disorders, such as Alzheimer's disease and Parkinson's disease. These changes in NGF levels may be an indication of the presence of these disorders and could be used as a diagnostic marker.

Conclusion

The KCNJ15 gene is a potential drug target and biomarker for the treatment of various neurological disorders. The neurotrophic factor, NGF, plays a crucial role in the development and maintenance of neural stem cells and has also been shown to play a key role in the regulation of pain. The KCNJ15 gene is a potential target for small molecule inhibitors of NGF action, and research into its potential as a drug or biomarker is an exciting area of study. Further research is needed to fully understand the role of NGF in neurological biology and its potential as a therapeutic agent.

Protein Name: Potassium Inwardly Rectifying Channel Subfamily J Member 15

Functions: Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium

The "KCNJ15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNJ15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets